Bond funds are subject to interest rate risk, which is the chance bond prices. overall will decline because of rising interest rates, and credit risk, which is the chance a bond issuer will. fail to pay interest and principal in a timely manner or that negative perceptions of the issuerâs ability to.
New Drug Treatment for IBS in Women. NOTE: On March 30, 2007 the FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable bowel syndrome with constipation and for patients younger than 65 years of age with chronic constipation.
Clinical updates. Current and future treatments for IBS-D. Irritable bowel syndrome (IBS) is a multifactorial disorder marked by recurrent abdominal pain or discomfort and altered bowel function. It affects between 10 and 20 percent of people in the developed world, about one-third of whom have IBS associated with diarrhea (IBS-D).